Profile | GDS2987 / GI_13994359-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 14.7 | 46 |
GSM215244 | HMVEC_vehicle_rep2 | 43.4 | 66 |
GSM215253 | HMVEC_vehicle_rep3 | ||
GSM215254 | HMVEC_atorvastatin_rep1 | 17.7 | 43 |
GSM215282 | HMVEC_atorvastatin_rep3 | ||
GSM215344 | HMVEC_atorvastatin_rep2 | 1.6 | 4 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 9.3 | 19 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 27.2 | 41 |
GSM215294 | HMVEC_SLx2119_rep1 | 16.2 | 49 |
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | 18.9 | 31 |
GSM215297 | PASMC_vehicle_rep1 | 14.9 | 23 |
GSM215298 | PASMC_vehicle_rep2 | ||
GSM215310 | PASMC_vehicle_rep3 | 4.3 | 7 |
GSM215311 | PASMC_atorvastatin_rep1 | ||
GSM215312 | PASMC_atorvastatin_rep2 | 40.7 | 53 |
GSM215313 | PASMC_atorvastatin_rep3 | 2.1 | 3 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 30.5 | 46 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | ||
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 42.5 | 57 |
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | ||
GSM215329 | PASMC_SLx2119_rep3 | 20.7 | 38 |
GSM215330 | Fibroblasts_vehicle_rep1 | 13.6 | 31 |
GSM215331 | Fibroblasts_vehicle_rep2 | 15.5 | 40 |
GSM215332 | Fibroblasts_vehicle_rep3 | 4.1 | 14 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 3.7 | 10 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 4.7 | 14 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 8.3 | 21 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 30.6 | 63 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 4.9 | 16 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 20.1 | 48 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 11.9 | 34 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 10 | 28 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 58.6 | 70 |